Company Overview and News

0
Check out top 10 stocks which moved the most last week; HDIL registers 50% gain

2018-08-19 moneycontrol
The market ended a truncated week on a good note, as benchmark indices closed with strong gains. The Nifty ended the day at a record closing high, while the Sensex ended higher by almost 300 points. Having said that, it failed to hold 38,000-mark.
PAGEIND 500449 UBL 532978 533155 TTNQY JUBLFOOD 532478 FILATEX RAIN BIRLAPREC 532540 JBLWY 509488 526227 522105 PGDQY EXIDEIND 517354 HVLQY GRAPHITE 532827 500339 UBHOLDINGS UNBWY HOCL EXQDY BAJAJFINSV BATAINDIA HAVELLS TCS 500086 507458 500043

0
D-Street Buzz: Metals loose shine with JSPL down 6%; Jubilant Foodworks hits fresh 52-week high

2018-08-10 moneycontrol
The Indian benchmark indices continues to trade in the red this Friday afternoon, but managed to regain some lost grounds with the Sensex down 67 points at 37,956 while the Nifty shed 15 points at 11,454.
SANOFI 532617 PRMQY 533155 532778 JUBLFOOD IDBLZ 532215 CADILAHC 505200 532960 532321 AXISBANK JBLWY 500674 HEROMOTOCO EICHERMOT 509488 YESBANK EXIDEIND ECQRY HINDALCO GRAPHITE AXB IBVENTURES IBN JETAIRWAYS CANFINHOME 532648 YYBKY 511196 PEL CDLYY AXBKY 500182 HNDNF AXBA EXQDY ICICIBANK BATAINDIA 532174 HRTQY 500302 LITL 500086 500043 500440

0
Exide plans to turn Haldia into battery-making hub in Southeast Asia

2018-08-07 moneycontrol
Exide Industries Ltd today set in motion efforts to turn its Haldia unit into one of the biggest battery-making centers in Southeast Asia, churning out everything from recycled lead to finished products.
EXIDEIND EXQDY 500086

0
Exide sees no #39;threat#39; from Suzuki#39;s lithium-ion battery plans

2018-08-06 moneycontrol
Exide Industries Ltd, India's largest automotive battery maker, sees no "major threat" from Japanese automobile giant Suzuki Motor Corp's proposed lithium-ion battery plant in Gujarat.
EXIDEIND EXQDY 7269 500086

0
Exide Industries Limited - Shareholders meeting

2018-08-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
EXIDEIND EXQDY 500086

0
Exide Industries Limited - Shareholders meeting

2018-08-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
EXIDEIND EXQDY 500086

4
Exide aiming to cut dependence on lead with new tech

2018-08-02 livemint
Kolkata: India’s largest automotive battery maker Exide Industries Ltd Thursday said it is planning to reduce dependence on lead—a key component of lead-acid batteries that it makes—by developing new technology with a US-based partner.
EXIDEIND EXQDY EXTC 500086

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...